FDA Drug Application (202799) for OMONTYS by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number202799
Product Number007
FormSOLUTION;INTRAVENOUS, SUBCUTANEOUS
DosageEQ 10MG BASE/ML (EQ 10MG BASE/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOMONTYS
Active IngredientPEGINESATIDE ACETATE

Active IngredientCount
List of drugs with Active Ingredient PEGINESATIDE ACETATE2


Back to FDA Applications sponsored by TAKEDA PHARMS USA